AstraZeneca: a mighty wind is blowin'
This article was originally published in Scrip
Executive Summary
Some big investors apparently want the head of AstraZeneca’s CEO David Brennan. Or at the very least, big investors have started to send signals of their disappointment with AZ’s senior management and the lack of transformation at the ailing pharma company.